14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
NNDM vs BNGO: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, Nano Dimension Ltd. (NNDM) is the stronger overall head-to-head candidate over Bionano Genomics, Inc. (BNGO) in the Tradestie Institutional Equity Comparison Engine, winning 5–2 core matrix metrics and 3–1 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). NNDM carries a Unified Composite Score of 41.2/100 (SELL) at $1.20 (N/M Forward P/E, -58.6% operating margin), whereas BNGO carries 46.0/100 (HOLD) at $0.94 (N/M Forward P/E, -97.1% operating margin).
Composite vs. Pillar Nuance: While BNGO currently prints a higher short-term Unified Composite Score (46.0/100 HOLD vs. NNDM 41.2/100 SELL), NNDM captures the overall institutional head-to-head verdict (5–2 matrix metrics and 3–1 across the 6 pillars) due to superior fundamental profitability (-58.6% vs. -97.1% operating margin) and revenue trajectory (+18.7% vs. +12.3% YoY).
Technical & Structure Timing Caution: NNDM is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 29.2); meanwhile BNGO is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 30.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on NNDM vs BNGO. Trailing 12-month operating profitability (NNDM -58.6% vs BNGO -97.1%) and valuation multiples (NNDM N/M vs BNGO N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Medical Instruments & Supplies value chain with $14.5M market capitalization and -97.1% operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ NNDM vs BNGO Key Questions & Quantitative Answers
As of Nov 16, 2026, Nano Dimension Ltd. (NNDM) is the stronger overall head-to-head candidate over Bionano Genomics, Inc. (BNGO) in the Tradestie Institutional Equity Comparison Engine, winning 5–2 core matrix metrics and 3–1 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). NNDM carries a Unified Composite Score of 41.2/100 (SELL) at $1.20 (N/M Forward P/E, -58.6% operating margin), whereas BNGO carries 46.0/100 (HOLD) at $0.94 (N/M Forward P/E, -97.1% operating margin). Composite vs. Pillar Nuance: While BNGO currently prints a higher short-term Unified Composite Score (46.0/100 HOLD vs. NNDM 41.2/100 SELL), NNDM captures the overall institutional head-to-head verdict (5–2 matrix metrics and 3–1 across the 6 pillars) due to superior fundamental profitability (-58.6% vs. -97.1% operating margin) and revenue trajectory (+18.7% vs. +12.3% YoY). Technical & Structure Timing Caution: NNDM is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 29.2); meanwhile BNGO is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 30.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
NNDM leads the Growth & Scale pillar: NNDM posts +18.7% YoY revenue growth and +0.0% YoY earnings growth on $126M TTM revenue (42.2% gross margin, -58.6% operating margin), compared with BNGO at +12.3% YoY revenue growth and +0.0% YoY earnings growth on $31M TTM revenue (48.0% gross margin, -97.1% operating margin). On trailing 12-month operating scale, NNDM generates $126M in USD-normalized revenue versus $31M for BNGO. In operating R&D and SG&A reinvestment, NNDM deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for BNGO.
BNGO screens cheaper on headline valuation multiples. NNDM trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 2.0x EV/Revenue (-45.8% EBITDA margin), whereas BNGO trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.9x EV/Revenue (-62.1% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against NNDM (-30.3% ROE) versus BNGO (-77.2% ROE) capital efficiency.
In options market volatility and institutional positioning, NNDM carries 103.9% implied volatility (100th %ile, Extreme (>80th %ile)), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.75β · 43% Vol realized risk). By comparison, BNGO carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.28β · 70% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.